Search Results - "MAGGIO, Aurelio"

Refine Results
  1. 1

    The New Voice for the New Era of Thalassemia Reports by Maggio, Aurelio

    Published in Thalassemia reports (01-03-2022)
    “…The recent transfer of Thalassemia Reports, the only journal fully dedicated on Thalassemia, from PagePress to MDPI was great news for those who contributed to…”
    Get full text
    Journal Article
  2. 2

    Antioxidant, Pro-Survival and Pro-Regenerative Effects of Conditioned Medium from Wharton’s Jelly Mesenchymal Stem Cells on Developing Zebrafish Embryos by Reina, Chiara, Cardella, Clara, Lo Pinto, Margot, Pucci, Gaia, Acuto, Santina, Maggio, Aurelio, Cavalieri, Vincenzo

    “…Conditioned media harvested from stem cell culturing have the potential to be innovative therapeutic tools against various diseases, due to their high content…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    CMR for myocardial iron overload quantification: calibration curve from the MIOT Network by Meloni, Antonella, Maggio, Aurelio, Positano, Vincenzo, Leto, Filippo, Angelini, Annalisa, Putti, Maria Caterina, Maresi, Emiliano, Pucci, Angela, Basso, Cristina, Marra, Martina Perazzolo, Pistoia, Laura, De Marchi, Daniele, Pepe, Alessia

    Published in European radiology (01-06-2020)
    “…Objectives R2* cardiac magnetic resonance (CMR) allows the non-invasive measurement of myocardial iron. We calibrated cardiac R2* values against myocardial…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    An optimized procedure for preparation of conditioned medium from Wharton’s jelly mesenchymal stromal cells isolated from umbilical cord by Acuto, Santina, Lo Iacono, Melania, Baiamonte, Elena, Lo Re, Rosa, Maggio, Aurelio, Cavalieri, Vincenzo

    Published in Frontiers in molecular biosciences (02-10-2023)
    “…Cell-free therapy based on conditioned medium derived from mesenchymal stromal cells (MSCs) has gained attention in the field of protective and regenerative…”
    Get full text
    Journal Article
  11. 11

    Bone Marrow Transplantation in Nonmalignant Haematological Diseases: What Have We Learned about Thalassemia? by Castagna, Luca, Tringali, Stefania, Sapienza, Giuseppe, Bono, Roberto, Di Maggio, Rosario, Maggio, Aurelio

    Published in Thalassemia reports (01-06-2023)
    “…Allogeneic stem cell transplantation remains the only therapy for congenital, severe haemoglobinopathies that is able to reverse the pathological phenotype. In…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia by Di Maggio, Rosario, Hsieh, Matthew M, Zhao, Xiongce, Calvaruso, Giuseppina, Rigano, Paolo, Renda, Disma, Tisdale, John F, Maggio, Aurelio

    “…In sickle cell disease (SCD), hydroxyurea (HU) treatment decreases the number of vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) by increasing fetal…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation by Di Maggio, Rosario, Giuliano, Alessandra, Renda, Disma, Calvaruso, Giuseppina, Raso, Simona, Pitrolo, Lorella, Carroccio, Antonio, Maggio, Aurelio

    Published in Thalassemia reports (01-09-2022)
    “…Venous thromboembolism (VTE) is a life-threatening complication, especially in case of recurrence. The appropriate duration of anticoagulant treatment…”
    Get full text
    Journal Article